Moberg Pharma AB (publ) (STO:MOB)

Sweden flag Sweden · Delayed Price · Currency is SEK
8.35
+0.72 (9.44%)
Mar 25, 2025, 5:29 PM CET
-63.72%
Market Cap 389.66M
Revenue (ttm) 9.81M
Net Income (ttm) -255.11M
Shares Out 46.69M
EPS (ttm) -6.74
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 165,597
Average Volume 157,889
Open 7.80
Previous Close 7.63
Day's Range 7.67 - 8.50
52-Week Range 6.34 - 40.90
Beta 0.85
RSI 47.55
Earnings Date May 13, 2025

About Moberg Pharma AB

Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products primarily in Sweden. It develops MOB-015, which has completed Phase III clinical trial for the treatment of nail fungus. The company was formerly known as Moberg Derma AB (publ) and changed its name to Moberg Pharma AB (publ) in May 2013. Moberg Pharma AB (publ) was incorporated in 2006 and is headquartered in Bromma, Sweden. [Read more]

Sector Healthcare
Founded 2006
Employees 9
Stock Exchange Nasdaq Stockholm
Ticker Symbol MOB
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.